Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
ID: 338351Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/338351

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-114.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering Administrative Supplements to support new cancer disparities research through the National Cancer Institute (NCI). This funding opportunity aims to engage investigators who typically do not focus on cancer disparities and encourages collaborations between seasoned cancer researchers and those specializing in cancer disparities, with the goal of enhancing multidisciplinary research addressing adverse differences in cancer outcomes among racial/ethnic minorities and underserved populations. Eligible applicants must hold active NCI awards that do not currently address cancer disparities, with a budget limit of $150,000 for a maximum of two years to expand existing projects. Interested parties can find more information and application details at the provided link, with the application deadline set for January 23, 2025.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-22-114.html
    The Department of Health and Human Services, through the National Cancer Institute (NCI), is offering Administrative Supplements to support new cancer disparities research. This funding opportunity aims to engage investigators who typically do not focus on cancer disparities and encourage collaborations between seasoned cancer researchers and those specializing in cancer disparities. The goal is to enhance multidisciplinary research addressing adverse differences in cancer outcomes among racial/ethnic minorities and underserved populations. Applications are invited to expand existing NCI-funded projects by incorporating a cancer disparities component, with a budget limit of $150,000 for a maximum of two years. Eligible applicants must hold active NCI awards that do not currently address cancer disparities. The initiative emphasizes research across various domains, including basic biology, prevention, treatment, and survivorship, particularly for cancers with documented health disparities. Key details include submission windows, requirements for electronic applications, and guidelines for collaboration. This effort supports the urgency to address cancer disparities and necessitates innovative approaches to existing research within the parameters of current funding mechanisms.
    Similar Opportunities
    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Basic Research in Cancer Health Disparities" under the R21 Exploratory/Developmental Research Grant mechanism. This initiative aims to support innovative research investigating the biological and genetic factors contributing to cancer health disparities among various racial and ethnic populations, with a focus on mechanistic studies and the development of new methodologies. The program is designed to foster collaboration among scientists and build a nationwide cohort dedicated to advancing the understanding of cancer disparities, ultimately leading to future R01 projects. Applications can be submitted starting September 16, 2024, with a budget cap of $275,000 over two years, and the closing date for submissions is November 16, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Supplements to Promote Diversity in Health-Related Research," aimed at enhancing diversity within the health research workforce. This initiative seeks to recruit and support individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds, while providing necessary accommodations for researchers with disabilities. The funding, which can reach up to $500,000, is available for administrative supplements to existing research grants, with applications undergoing administrative review rather than peer review. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
    Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE)" aimed at fostering collaborations between institutions serving underserved populations and NCI-designated Cancer Centers. The initiative seeks to enhance cancer research capacity, promote workforce diversity, and implement community outreach initiatives to address cancer health disparities. This program is vital for developing comprehensive research projects that include administrative cores, research education, and outreach efforts, ultimately contributing to a stronger national cancer program. Eligible applicants can request funding of up to $2.2 million over five years, with the application submission period starting on December 15, 2023. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities" (R01, Clinical Trial Required). This initiative aims to solicit applications for projects that identify and address barriers to cancer screening and preventive services, particularly in underserved populations, through multi-level interventions involving patients, clinicians, healthcare settings, and community partners. The focus is on developing evidence-based strategies to improve cancer outcomes for groups such as Black Americans, Hispanics, and Native Americans, emphasizing health equity and structured research methodologies. Interested applicants can find more details and submit proposals by January 7, 2027, with the first application due date being October 5, 2023. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov, and further information is available at NIH Grants.
    Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research" (R21 Clinical Trial Not Allowed). This funding opportunity aims to enhance diversity among early-stage and junior investigators in cancer research, particularly from groups that are underrepresented in the biomedical, behavioral, clinical, and social sciences. The initiative encourages innovative studies in cancer biology, with a maximum funding amount of $275,000 available over a two-year period, and applications must demonstrate scientific merit and innovation. The application window opens on May 17, 2024, with the first awards expected to be made in June 2024; interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required), aimed at enhancing diversity within the cancer research workforce. This grant provides salary and research support for individuals from underrepresented backgrounds who are committed to leading independent clinical trials, with a focus on fostering their career development through mentorship. The program is crucial for addressing health disparities in cancer outcomes and encourages applications from those facing systemic barriers in the field. Interested applicants can receive up to $100,000 annually for salaries and an additional $30,000 for research-related expenses, with applications due by November 12, 2024. For further inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-21-296.html.
    Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Administrative Supplements to existing NIH grants and cooperative agreements to address unforeseen costs that arise within the scope of approved awards. This funding opportunity is designed for organizations holding eligible parent awards, allowing them to apply for additional support when costs increase or new research objectives emerge. The initiative underscores NIH's commitment to facilitating ongoing research by providing flexible funding options, although applicants should note that funding availability is not guaranteed and depends on appropriations and the merit of applications. Interested parties can find more information and submit inquiries to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV, with applications due by January 24, 2025.
    Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (CHD-MH) (U54 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (CHD-MH), under the funding opportunity RFA-CA-24-020. This initiative aims to establish a network of multidisciplinary programs dedicated to translational cancer research, specifically targeting prevention, early detection, treatment, and diagnosis in underserved populations affected by cancer. The program requires applicants to propose at least three research projects supported by comprehensive infrastructure, including various cores such as Administrative, Shared Resources, Developmental Research Program, and Career Enhancement Program, with a maximum budget request of $1.6 million annually over five years. Interested applicants must submit their proposals by September 27, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The total funding available for this opportunity is approximately $80 million, expected to be distributed among around four awards.
    NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Research Scientist Development Award to Promote Diversity (K01), a federal grant aimed at enhancing diversity within the cancer research workforce. This funding opportunity supports individuals from underrepresented backgrounds in biomedical and clinical sciences by providing salary and research support for a period of 3 to 5 years under the mentorship of experienced researchers, specifically for projects that do not involve leading independent clinical trials. The initiative is crucial for addressing disparities in cancer incidence and mortality rates among underserved populations, fostering a diverse pool of research talent, and promoting innovative solutions to complex health challenges. Interested applicants must submit their proposals by November 12, 2024, and can find additional information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.